Migon Tablet is a prescription-only medication indicated for the treatment of migraine and prevention of vasospasm. The active ingredient, flunarizine, is a calcium channel blocker that exerts its therapeutic effects by antagonizing the activity of calcium ions, thereby reducing the release of neurotransmitters that mediate vasoconstriction. The recommended dose is one tablet twice daily, taken with a glass of water. Migon Tablet has been shown to be effective in reducing the frequency and severity of migraine attacks, as well as alleviating symptoms such as nausea, vomiting, and sensitivity to light and sound. In addition, it has been demonstrated to prevent vasospasm and reduce the risk of ischemic events. The most common adverse effects include dizziness, drowsiness, and headache, which are generally mild and transient. Migon Tablet is contraindicated in patients with a history of cardiac conduction disorders, liver or kidney disease, and hypersensitivity to flunarizine. As with any medication, patients should be monitored for signs of overdose, which can lead to increased heart rate, blood pressure, and cardiac arrhythmias.